Search Page

1

Cite

Share

Methylnaltrexone.

Hendrikx JJ, Beijnen JH, Schellens JH. Hendrikx JJ, et al. Oncologist. 2009 Jul;14(7):679-82. doi: 10.1634/theoncologist.2009-0049. Epub 2009 Jul 15. Oncologist. 2009. PMID: 19605844 Free article. Review. No abstract available.

Cite

Share

2

Cite

Share

Highlight selection of radiochemistry and radiopharmacy developments by editorial board.

Alves F, Antunes IF, Cazzola E, Cleeren F, Cornelissen B, Denkova A, Engle J, Faivre-Chauvet A, Gillings N, Hendrikx JJMA, Jalilian AR, van der Meulen NP, Mikolajczak R, Neels OC, Pillai MRA, Reilly R, Rubow S, Seimbille Y, Spreckelmeyer S, Szymanski W, Taddei C. Alves F, et al. Among authors: hendrikx jjma. EJNMMI Radiopharm Chem. 2021 Sep 8;6(1):31. doi: 10.1186/s41181-021-00146-9. EJNMMI Radiopharm Chem. 2021. PMID: 34495412 Free PMC article. Review.

Cite

Share

3

Cite

Share

Fixed Dosing of Monoclonal Antibodies in Oncology.

Hendrikx JJMA, Haanen JBAG, Voest EE, Schellens JHM, Huitema ADR, Beijnen JH. Hendrikx JJMA, et al. Oncologist. 2017 Oct;22(10):1212-1221. doi: 10.1634/theoncologist.2017-0167. Epub 2017 Jul 28. Oncologist. 2017. PMID: 28754722 Free PMC article. Review.

Cite

Share

4

Cite

Share

P-gp and taxanes.

Hendrikx JJ, Beijnen JH, Schinkel AH. Hendrikx JJ, et al. Oncoscience. 2014 Jun 19;1(7):478-9. doi: 10.18632/oncoscience.56. eCollection 2014. Oncoscience. 2014. PMID: 25594047 Free PMC article. No abstract available.

Cite

Share

5

Cite

Share

Apical ABC transporters and cancer chemotherapeutic drug disposition.

Durmus S, Hendrikx JJ, Schinkel AH. Durmus S, et al. Among authors: hendrikx jj. Adv Cancer Res. 2015;125:1-41. doi: 10.1016/bs.acr.2014.10.001. Epub 2015 Jan 8. Adv Cancer Res. 2015. PMID: 25640265 Review.

Cite

Share

6

Cite

Share

Unraveling the complexity of therapeutic drug monitoring for monoclonal antibody therapies to individualize dose in oncology.

Chatelut E, Hendrikx JJMA, Martin J, Ciccolini J, Moes DJAR. Chatelut E, et al. Among authors: hendrikx jjma. Pharmacol Res Perspect. 2021 Apr;9(2):e00757. doi: 10.1002/prp2.757. Pharmacol Res Perspect. 2021. PMID: 33745217 Free PMC article. Review.

Cite

Share

7

Cite

Share

Follow up survey for implementation of fixed-dosing of monoclonal antibodies.

Heinhuis KM, Beijnen JH, Hendrikx JJMA. Heinhuis KM, et al. Among authors: hendrikx jjma. Int J Clin Pharm. 2020 Feb;42(1):3-6. doi: 10.1007/s11096-020-00971-z. Epub 2020 Feb 5. Int J Clin Pharm. 2020. PMID: 32026351

Cite

Share

8

Cite

Share

Genetically modified mouse models for oral drug absorption and disposition.

Tang SC, Hendrikx JJ, Beijnen JH, Schinkel AH. Tang SC, et al. Among authors: hendrikx jj. Curr Opin Pharmacol. 2013 Dec;13(6):853-8. doi: 10.1016/j.coph.2013.08.011. Epub 2013 Sep 8. Curr Opin Pharmacol. 2013. PMID: 24021267 Review.

Cite

Share

9

Cite

Share

No relation between docetaxel administration route and high-grade diarrhea incidence.

Hendrikx JJMA, Stuurman FE, Song JY, de Weger VA, Lagas JS, Rosing H, Beijnen JH, Schinkel AH, Schellens JHM, Marchetti S. Hendrikx JJMA, et al. Pharmacol Res Perspect. 2020 Aug;8(4):e00633. doi: 10.1002/prp2.633. Pharmacol Res Perspect. 2020. PMID: 32725720 Free PMC article. Clinical Trial.

Cite

Share

10

Cite

Share

Haematotoxicity during peptide receptor radionuclide therapy: Baseline parameters differences and effect on patient's therapy course.

de Vries-Huizing DMV, Versleijen MWJ, Sinaasappel M, Walraven I, Geluk-Jonker MM, Tesselaar MET, Hendrikx JJMA, de Wit-van der Veen BJ, Stokkel MPM. de Vries-Huizing DMV, et al. Among authors: hendrikx jjma. PLoS One. 2021 Nov 18;16(11):e0260073. doi: 10.1371/journal.pone.0260073. eCollection 2021. PLoS One. 2021. PMID: 34793530 Free PMC article.

Cite

Share